Immune cells play an important role in maintaining tumor progression in the TME including the regulation of antitumor immune cells (CD8+T, M1-like TAMs) and protumor immune cells (Tregs, MDSCs, and M2-like TAMs) [37]. The gene discussed is CD8A; the disease is neoplasm.